|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.94 USD | -0.81% |
|
+3.47% | +1.84% |
| 02/12 | Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge | MT |
| 06/11 | The Market Can't Make Up Its Mind |
Company Valuation: UMB Financial Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,314 | 5,131 | 4,035 | 4,055 | 5,507 | 8,730 | - | - |
| Change | - | 54.86% | -21.36% | 0.49% | 35.83% | 58.52% | - | - |
| Enterprise Value (EV) | 3,314 | 5,131 | 4,035 | 4,055 | 5,507 | 8,730 | 8,730 | 8,730 |
| Change | - | 54.86% | -21.36% | 0.49% | 35.83% | 58.52% | 0% | 0% |
| P/E ratio | 11.6x | 14.7x | 9.43x | 11.6x | 12.6x | 12.9x | 9.96x | 9.02x |
| PBR | 1.1x | 1.63x | 1.51x | 1.31x | 1.59x | 1.18x | 1.07x | 0.97x |
| PEG | - | 0.7x | 0.4x | -0.6x | 0.5x | -12.61x | 0.3x | 0.9x |
| Capitalization / Revenue | 2.57x | 4x | 2.75x | 2.72x | 3.33x | 3.35x | 3.1x | 2.91x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.35x | 3.1x | 2.91x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 7.84x | 6.79x | 6.18x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1.25 | 1.38 | 1.49 | 1.53 | 1.57 | 1.624 | 1.704 | 1.729 |
| Rate of return | 1.81% | 1.3% | 1.78% | 1.83% | 1.39% | 1.41% | 1.48% | 1.5% |
| EPS 2 | 5.93 | 7.24 | 8.86 | 7.18 | 8.99 | 8.898 | 11.54 | 12.74 |
| Distribution rate | 21.1% | 19.1% | 16.8% | 21.3% | 17.5% | 18.2% | 14.8% | 13.6% |
| Net sales 1 | 1,291 | 1,283 | 1,468 | 1,488 | 1,655 | 2,607 | 2,817 | 3,004 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 469.4 | 449.1 | 571.5 | 524.8 | 625.8 | 1,114 | 1,287 | 1,413 |
| Net income 1 | 286.5 | 353 | 431.7 | 350 | 441.2 | 666 | 886.9 | 981.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 68.99 | 106.11 | 83.52 | 83.55 | 112.86 | 114.94 | 114.94 | 114.94 |
| Nbr of stocks (in thousands) | 48,031 | 48,359 | 48,312 | 48,531 | 48,798 | 75,955 | - | - |
| Announcement Date | 26/01/21 | 25/01/22 | 24/01/23 | 30/01/24 | 28/01/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.92x | - | - | 1.41% | 873.02Cr | ||
| 6.52x | - | - | 4.75% | 38TCr | ||
| 19.39x | - | - | 0.89% | 11TCr | ||
| 14.59x | - | - | 4.75% | 7.07TCr | ||
| 5.82x | - | - | 5.1% | 6.23TCr | ||
| 17.8x | - | - | 3.71% | 6.13TCr | ||
| 7.22x | - | - | 6.92% | 5.91TCr | ||
| 6.45x | - | - | 4.72% | 5.82TCr | ||
| 10.49x | - | - | 4.01% | 4.56TCr | ||
| Average | 11.25x | 4.03% | 9.47TCr | |||
| Weighted average by Cap. | 9.94x | 4.27% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- UMBF Stock
- Valuation UMB Financial Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















